Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|August 18, 2017
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosisJingang Huang, Christiane Maier, Yun Zhang, et al.
Annals of the Rheumatic Diseases|January 17, 2014
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosisYun Zhang, Clara Dees, Christian Beyer, et al.
Annals of the Rheumatic Diseases|January 16, 2015
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosisTatjana Mallano, Katrin Palumbo-Zerr, Pawel Zerr, et al.
Annals of the Rheumatic Diseases|November 22, 2013
Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signallingAlfiya Distler, Clara Ziemer, Christian Beyer, et al.
Annals of the Rheumatic Diseases|January 23, 2014
Vitamin D receptor regulates TGF-β signalling in systemic sclerosisPawel Zerr, Stefan Vollath, Katrin Palumbo-Zerr, et al.
Arthritis and Rheumatism|March 2, 2011
Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosisJérôme Avouac, Barbara G Fürnrohr, Michal Tomcik, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosisChristian Beyer, Nicole Reich, Sonia C Schindler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 27, 2014
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosisJérôme Avouac, Katrin Palumbo-Zerr, Nadira Ruzehaji, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosisAngelika Horn, Trayana Kireva, Katrin Palumbo-Zerr, et al.
Oncoimmunology|June 28, 2021
Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adultsAditya Arra, Maximilian Pech, Hang Fu, et al.
Pageof 15